Moderna Initiated Buy at Jefferies, Will Be Added to Nasdaq 100 – TheStreet

Moderna (MRNA) – Get Report increased after Jefferies expert Michael Yee started coverage of the biopharmaceutical company with a buy rating and a share-price target of $90, and Nasdaq stated it would a. [+1383 chars]